Bayesian Capital Management, LP Boston Scientific Corp Transaction History

Bayesian Capital Management, LP

$838 Million
Q3 2024

A detailed history of Bayesian Capital Management, LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Bayesian Capital Management, LP holds 36,800 shares of BSX stock, worth $3.31 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

36,800

Previous 43,300 15.01%

Holding current value

$3.31 Million

Previous $3.33 Million 7.53%

% of portfolio

0.37%

Previous 0.39%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$72.96 - $84.0 $474,239 - $546,000	-6,500 Reduced 15.01%	36,800 $3.08 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $60,597 - $69,939	-900 Reduced 2.04%	43,300 $3.33 Million
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $69,120 - $82,344	-1,200 Reduced 2.64%	44,200 $3.03 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $1.07 Million - $1.27 Million	22,000 Added 94.02%	45,400 $2.62 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $642,432 - $699,904	12,800 Added 120.75%	23,400 $1.24 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $3.74 Million - $4.11 Million	-75,200 Reduced 87.65%	10,600 $573,000
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $2.74 Million - $3.04 Million	60,712 Added 242.0%	85,800 $4.29 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $992,481 - $1.18 Million	25,088 New	25,088 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $109,244 - $146,010	3,100 Added 6.12%	53,788 $2.01 Million
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $1.92 Million - $2.12 Million	-46,901 Reduced 48.06%	50,688 $2.25 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $2.14 Million - $2.52 Million	56,200 Added 135.78%	97,589 $4.15 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $1.14 Million - $1.27 Million	27,600 Added 200.16%	41,389 $1.8 Million
Q2 2021 Aug 13, 2021	SELL	$38.58 - $44.24 $949,492 - $1.09 Million	-24,611 Reduced 64.09%	13,789 $590,000
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $3.31 Million - $3.73 Million	-93,900 Reduced 70.98%	38,400 $1.48 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $2.68 Million - $3.39 Million	80,700 Added 156.4%	132,300 $4.76 Million
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $334,068 - $409,630	9,700 Added 23.15%	51,600 $1.97 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $220,387 - $285,503	7,300 Added 21.1%	41,900 $1.47 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $534,681 - $946,197	20,700 Added 148.92%	34,600 $1.13 Million
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $526,393 - $630,643	13,900 New	13,900 $629,000

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account

Bayesian Capital Management, LP Boston Scientific Corp Transaction History